Company page
Hybio Pharmaceutical Co., Ltd. Class A
Hybio Pharmaceutical Co., Ltd. Class A is a publicly traded company in China, with a market capitalization of approximately 2.76 billion USD. The company focuses on the pharmaceutical industry, providing a range of products and services. As a key player in its market, Hybio is committed to advancing healthcare solutions and improving patient outcomes.

- Ticker
- 300199:SZSE
- Asset type
- Stock
- Market cap
- $2.76B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SZSE
- Currency
- CNY